Development and preliminary testing of a brief clinical tool to enable daily monitoring of chemotherapy toxicity: The Daily Chemotherapy Toxicity self-Assessment Questionnaire-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development and preliminary testing of a brief clinical tool to enable daily monitoring of chemotherapy toxicity: The Daily Chemotherapy Toxicity self-Assessment Questionnaire

Published:2018-07-11 Issue:6 Volume:27 Page:e12890
ISSN:0961-5423
Container-title:European Journal of Cancer Care
language:en
Short-container-title:Eur J Cancer Care

Author:

Maguire Roma¹,Kotronoulas Grigorios²^ORCID,Donnan Peter T.³,Paterson Catherine⁴^ORCID,McCann Lisa¹,Connaghan John¹,Di Domenico David G. G.⁵,Kearney Nora⁶

Affiliation:

1. Department of Computer and Information Sciences; University of Strathclyde; Glasgow UK

2. School of Medicine, Dentistry and Nursing; University of Glasgow; Glasgow UK

3. Population Health Sciences; Medical Research Institute; University of Dundee; Dundee UK

4. School of Nursing and Midwifery; Robert Gordon University; Aberdeen UK

5. School of Health, Wellbeing and Social Care; Faculty of Wellbeing, Education and Language Studies; The Open University; Edinburgh UK

6. School of Nursing, Midwifery and Health Systems; University College Dublin; Dublin Ireland

Funder

NHS Scotland

Burdett Trust for Nursing

Philips Healthcare Incubator

Publisher

Wiley

Subject

Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ecc.12890/fullpdf

Reference50 articles.

1. Development and testing of the patient-reported chemotherapy indicators of symptoms and experience: Patient-reported outcome and process indicators sensitive to the quality of nursing care in ambulatory chemotherapy settings;Armes;Cancer Nursing,2014

2. Symptom monitoring with patient-reported outcomes during routine cancer treatment: A randomized controlled trial;Basch;Journal of Clinical Oncology,2016

3. Adverse symptom event reporting by patients vs clinicians: Relationships with clinical outcomes;Basch;Journal of the National Cancer Institute,2009

4. Development of the national cancer institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE);Basch;Journal of the National Cancer Institute,2014

5. Are chemotherapy-associated symptoms underestimated? A view beyond common toxicity criteria

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Involving Patients and Clinicians in the Design of Wireframes for Cancer Medicines Electronic Patient Reported Outcome Measures in Clinical Care: Mixed Methods Study;JMIR Formative Research;2023-12-21

2. Facilitator of change: Patients’ and clinicians’ experiences using ASyMS, a real-time remote monitoring system for chemotherapy symptom management (Preprint);2023-10-25

3. Involving Patients and Clinicians in the Design of Wireframes for Cancer Medicines Electronic Patient Reported Outcome Measures in Clinical Care: Mixed Methods Study (Preprint);2023-04-18

4. Development of an eHealth Tool for Capturing and Analyzing the Immune-related Adverse Events (irAEs) in Cancer Treatment;Cancer Informatics;2023-01

5. Development of an EORTC Item Bank for Computer-Adaptive Testing of Nausea and Vomiting;Seminars in Oncology Nursing;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3